Search Results - "Taha, Mohamad B"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Left Ventricular Strain Is Associated With Myocardial Recovery Following ST-Elevation Myocardial Infarction, a Prospective Longitudinal CMR Study by Taha, Mohamad B, Jeng, Eric I, Salerno, Michael, Moguillansky, Diego, Keeley, Ellen C, Al-Ani, Mohammad A

    Published in Frontiers in cardiovascular medicine (24-02-2022)
    “…Infarct size following ST-elevation myocardial infarction (STEMI) is an important determinate of left ventricular (LV) dysfunction and cardiovascular morbidity…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants by Herzallah, Mohammad M, Moustafa, Ahmed A, Natsheh, Joman Y, Abdellatif, Salam M, Taha, Mohamad B, Tayem, Yasin I, Sehwail, Mahmud A, Amleh, Ivona, Petrides, Georgios, Myers, Catherine E, Gluck, Mark A

    Published in Frontiers in integrative neuroscience (01-01-2013)
    “…One barrier to interpreting past studies of cognition and major depressive disorder (MDD) has been the failure in many studies to adequately dissociate the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Chronic elevation of cardiac troponin I predicts the extent of coronary disease in hemodialysis patients presenting with acute enzyme elevation by Taha, Mohamad B., Taha, Ahmad B., Dasa, Osama, Alom, Modar, Abdelgadir, Yasir H., Winchester, David E.

    Published in American heart journal plus (01-02-2021)
    “…Elevation of cardiac troponin I (cTn-I) is associated with coronary artery disease (CAD) in asymptomatic patients with end-stage renal disease (ESRD) receiving…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013-2018 by Taha, Mohamad B, Valero-Elizondo, Javier, Yahya, Tamer, Caraballo, César, Khera, Rohan, Patel, Kershaw V, Ali, Hyeon Ju R, Sharma, Garima, Mossialos, Elias, Cainzos-Achirica, Miguel, Nasir, Khurram

    Published in Diabetes care (01-03-2022)
    “…Health-related expenditures resulting from diabetes are rising in the U.S. Medication nonadherence is associated with worse health outcomes among adults with…”
    Get full text
    Journal Article
  11. 11

    Team-based strategies to prevent heart failure by Taha, Mohamad B., Patel, Kershaw V., Nasir, Khurram

    Published in Current opinion in cardiology (01-05-2022)
    “…The burden of heart failure (HF) in the United States and worldwide is projected to rise. Prevention of HF can curb the burden of this chronic syndrome, but…”
    Get full text
    Journal Article
  12. 12

    Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management by Taha, Mohamad B., Yahya, Tamer, Satish, Priyanka, Laird, Rachel, Agatston, Arthur S., Cainzos-Achirica, Miguel, Patel, Kershaw V., Nasir, Khurram

    Published in Current atherosclerosis reports (01-08-2022)
    “…Purpose of Review The burden of obesity worldwide is high and projected to rise. Obesity increases the risk of several cardiovascular diseases and…”
    Get full text
    Journal Article
  13. 13

    Estradiol shifts interactions between the infralimbic cortex and central amygdala to enhance fear extinction memory in female rats by Maeng, Lisa Y., Cover, Kara K., Taha, Mohamad B., Landau, Aaron J., Milad, Mohammed R., Lebrón‐Milad, Kelimer

    Published in Journal of neuroscience research (01-01-2017)
    “…There is growing evidence that estradiol (E2) enhances fear extinction memory consolidation. However, it is unclear how E2 influences the nodes of the fear…”
    Get full text
    Journal Article
  14. 14

    1500-PUB: Characteristics of Inpatients with DKA and SGLT2i Use at a Tertiary Hospital by WILLIAMSON, SHELLEY, TAHA, MOHAMAD B., BROWN, TIMOTHY R., HEBERT, SEAN, PATEL, KERSHAW, NARCISSE, III, VICTOR J., SADHU, ARCHANA R.

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Background: SGLT-2 inhibitors (SGLT2i) have cardiovascular and renal benefits but pose an increased risk of DKA. The risk factors for developing DKA while on…”
    Get full text
    Journal Article
  15. 15

    Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events by Acquah, Isaac, Cainzos-Achirica, Miguel, Taha, Mohamad B., Lahan, Shubham, Blaha, Michael J., Al-Kindi, Sadeer G., Khan, Safi U., Sharma, Garima, Budoff, Matthew J., Nasir, Khurram

    Published in Atherosclerosis (01-01-2024)
    “…Social determinants of health (SDOH) are key for the identification of populations at increased risk of atherosclerotic cardiovascular disease (ASCVD)…”
    Get full text
    Journal Article
  16. 16

    Cumulative Social Disadvantage and All-Cause Mortality in the United States: Findings from a National Study by Javed, Zulqarnain, Valero-Elizondo, Javier, Khan, Safi U, Taha, Mohamad B, Maqsood, Muhammad Haisum, Mossialos, Elias, Sharma, Garima, Hyder, Adnan A, Cainzos-Achirica, Miguel, Nasir, Khurram

    Published in Population health management (01-12-2022)
    “…The extent to which cumulative social disadvantage-defined as aggregate social risk resulting from multiple co-occurring adverse social determinants of health…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Implementation of Cardiometabolic Centers and Training Programs by Taha, Mohamad B., Rao, Neha, Vaduganathan, Muthiah, Cainzos-Achirica, Miguel, Nasir, Khurram, Patel, Kershaw V.

    Published in Current diabetes reports (01-05-2022)
    “…Purpose of Review Type 2 diabetes is frequently accompanied by obesity, nonalcoholic fatty liver disease, chronic kidney disease, and cardiovascular disease,…”
    Get full text
    Journal Article
  19. 19

    A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease by Taha, Mohamad B., Avenatti, Eleonora, Li, Daniel S., Ohonba, Tirhas, Cainzos-Achirica, Miguel, Patel, Kershaw V, Nasir, Khurram

    Published in Methodist DeBakey cardiovascular journal (24-09-2021)
    “…Compelling results from clinical trials supporting intensive risk-reduction therapies to reduce associated morbidity and mortality in patients with established…”
    Get full text
    Journal Article
  20. 20

    UTILIZATION OF OPTIMAL MEDICAL PHARMACOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM AN INTEGRATED HEALTHCARE SYSTEM by Shahid, Izza, Bose, Budhaditya, Avenatti, Eleonora, Khan, Safi U., Taha, Mohamad B., Nasir, Khurram

    Published in American journal of preventive cardiology (01-09-2023)
    “…Pharmacologic Therapy Patients with atherosclerotic cardiovascular disease (ASCVD) and concurrent type 2 diabetes mellitus (T2DM) are at an increased risk for…”
    Get full text
    Journal Article